About Us

Candesant’s mission is to offer an uncomplicated, effective alternative to current therapies to improve the lives of people who sweat too much. All 84 million of them¹.

Candesant Biomedical

Candesant Biomedical is a clinical stage company focused on development of a novel treatment for the non-invasive treatment of excessive sweating or hyperhidrosis.

The company’s lead investigational product is a topical patch to conveniently treat excessive sweating with a quick, in-office procedure. 

Two successful clinical studies demonstrated efficacy in reducing sweat and validated that the energy is reproducibly generated, highly targeted and appears to inactivate the most active sweat glands.

In these initial clinical studies, Candesant’s investigational treatment demonstrated significant sweat reduction benefits lasting up to 2 months after a single, no down-time treatment.


Leadership

Candesant is led by a deeply experienced team of drug and device development professionals passionate about meeting real patient and physician needs.

Niquette Hunt

Founder and CEO

Niqui has over 25 years experience in developing, launching and commercially scaling 20+ products.

Read More

Jacob Waugh, MD

Founder and Chief Scientific Officer

Jacob Waugh has more than 25 years in scientific innovation and development.

Read More

Mary Beth Kreissler

Chief Financial Officer

Mary Beth has 20 years’ experience with pre-revenue and early commercialization stage companies in tech and life sciences.

Read More

Erica Bazerkanian

Head, Commercial Development

Erica Bazerkanian has 25 years’ experience in commercial strategy, new product development and market creation.

Read More

Jesse Rosen

VP Product Development

Jesse has 20+ years of experience in the design, development and manufacturing of medical devices.

Read More

Erin Tims

Senior Director, Clinical Affairs

Erin has 15 years experience in the design and execution of clinical studies across various therapeutic categories.

Read More

Scott Wilson

Head, Regulatory Affairs

Scott has over 25 years' experience in the medical device industry, specializing in regulatory affairs and quality.

Read More

Board of Directors

Ellie McGuire

Ellie McGuire is a partner of the LS Polaris Innovation Fund. McGuire currently serves on the Boards of Montis Biosciences and Mellitus.

Read More

Robert Grove

Robert is an experienced business executive and serial entrepreneur with 35+ years in the medical laser industry.

Read More

Samara Braunstein

Samara Braunstein is a marketing and financial professional with decades of experience in healthcare, consumer products, and finance.

Read More

Michael Kane, MD

Michael is an aesthetic plastic surgeon and entrepreneur who has been practicing in New York City for more than 25 years.

Read More
Scroll to Top